Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sathish Subbaiah

Neurological Surgery Centereach, NY Medical Doctor

NPI 1598932162 CMS profile 722393

2112 Middle Country Rd, Centereach, NY 11720

Open in the dashboard

General payments

$3,494

38 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sathish Subbaiah of Centereach, NY is reported in the CMS Open Payments database as having received $3,494 across 38 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 52nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,706 13
2024 General $32 2
2023 General $477 6
2022 General $188 2
2020 General $188 3
2019 General $903 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sathish Subbaiah
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Sathish Subbaiah were reported at $1,706. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Sathish Subbaiah Neurological Surgery median Middle half National median
2019 $903 $582 $138–$3,006 $163
2020 $188 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $188 $542 $139–$2,989 $149
2023 $477 $534 $145–$2,697 $160
2024 $32 $574 $155–$3,046 $164
2025 $1,706 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $1,428 4 payments
  2. Stryker Corporation $447 4 payments
  3. Intrinsic Therapeutics $417 4 payments
  4. DePuy Synthes Sales Inc. $287 10 payments
  5. NuVasive, Inc. $222 3 payments
  6. SI-BONE, Inc. $144 1 payment
  7. Relievant Medsystems, Inc. $123 1 payment
  8. Orthofix Medical, Inc. $118 6 payments
  9. Djo, LLC $100 1 payment
  10. Spine Wave, Inc. $98 1 payment
  11. Other $110 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,863 34 payments
  2. Travel and Lodging $1,632 4 payments
Products named General payments · program years 2019–2025
  1. SABLE $1,145 2 payments
  2. XIA $447 4 payments
  3. EXCELSIUS GPS $264 1 payment
  4. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $246 3 payments
  5. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $246 3 payments
  6. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Orthopedic $171 1 payment
  7. IFUSE IMPLANT $144 1 payment
  8. TLX $133 1 payment
  9. COHERE $133 1 payment
  10. MaXcess-C $133 1 payment
  11. Other $1,213 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

284

Median for Neurosurgery: 83

Drug cost

$1,806

Median for Neurosurgery: $872

Branded share of claims

10.6%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tizanidine Hcl Generic 114 $823
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 30 $290
Gabapentin Generic 27 $251
Meloxicam Generic 56 $161
Methocarbamol Generic 13 $87
Methylprednisolone Generic 11 $79
Cyclobenzaprine Hcl Generic 13 $72
Tramadol Hcl Generic 20 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$159,987

Medicare's payments for the services billed

Medicare patients

283

Average age 72

Services billed

774

143 women, 140 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Ischemic heart disease 36%
Diabetes 32%
Chronic kidney disease 19%
COPD 19%
Osteoporosis 19%
Depression 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

38 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record